Catalent completes Juniper merger to ‘expand and strengthen’ oral dose manufacturing

12:44 EDT 14 Aug 2018 | Outsourcing-Pharma

Juniper Pharmaceuticals will become a wholly owned subsidiary of Catalent Pharma Solutions today, says the CDMO.

More From BioPortfolio on "Catalent completes Juniper merger to ‘expand and strengthen’ oral dose manufacturing"